Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 232,000 | 221,000 | 207,000 | 223,000 | 187,000 |
| Cost of Goods | 40,000 | 38,000 | 37,000 | 39,000 | 26,000 |
| Gross Profit | 192,000 | 183,000 | 170,000 | 184,000 | 161,000 |
| Operating Expenses | 136,000 | 120,000 | 116,000 | 139,000 | 123,000 |
| Operating Income | 56,000 | 63,000 | 54,000 | 45,000 | 38,000 |
| Interest Expense | 8,000 | 7,000 | 6,000 | 6,000 | 7,000 |
| Other Income | 6,000 | 2,000 | 0 | 1,000 | 0 |
| Pre-tax Income | 54,000 | 58,000 | 48,000 | 40,000 | 31,000 |
| Income Tax | 13,000 | 10,000 | 7,000 | 4,000 | 4,000 |
| Net Income Continuous | 41,000 | 48,000 | 41,000 | 36,000 | 27,000 |
| Net Income | $41,000 | $48,000 | $41,000 | $36,000 | $27,000 |
| EPS Basic Total Ops | 0.29 | 0.34 | 0.29 | 0.28 | 0.18 |
| EPS Basic Continuous Ops | 0.29 | 0.34 | 0.29 | 0.26 | 0.18 |
| EPS Diluted Total Ops | 0.28 | 0.33 | 0.28 | 0.27 | 0.18 |
| EPS Diluted Continuous Ops | 0.28 | 0.33 | 0.28 | 0.26 | 0.18 |
| EBITDA(a) | $62,000 | $69,000 | $59,000 | $49,000 | $44,000 |